Back to Catalog
Stipple Bio
stipplebio
Preclinical ADC oncology company targeting tumor specific epitopes.
Total Funding
$100M
sector:biotech
stage:series_a
oncology
ADC
antibody-drug-conjugate
precision-medicine
epitope-targeting
preclinical
Cambridge-MA
Full Profile Gated
Register as a Qualified Purchaser to access the full profile of Stipple Bio, including financial analysis, competitive landscape, and investment thesis.